# Metagenomi Therapeutics, Inc.: Form S-1/A, filed Feb 7, 2024

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: S-1/A
- Filed: 2024-02-07
- Accepted by EDGAR: Feb 7, 2024, 16:07 ET
- Period: not reported
- Accession: 0001193125-24-026662
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000119312524026662/d425213ds1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000119312524026662/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000119312524026662/d425213ds1a.htm

Filed Feb 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-026662. Last ingested by Listed: Nov 11, 2026, 00:33 ET. No prices; not investment advice.
